GC61346
Pralsetinib
Also listed as trans-Pralsetinib
trans-Pralsetinib (trans-BLU-667) is a rearranged during transfection (RET) inhibitor extracted from patent US20170121312A1, Compound Example 129
ChemicalCAS2097132-93-7MW533.6FormulaC27H32FN9O2
- CAS number
- 2097132-93-7
- Molecular weight
- 533.6
- Formula
- C27H32FN9O2
- InChIKey
- GBLBJPZSROAGMF-SIYOEGHHSA-N
- Catalogue number
- GC61346
- Brand
- GLPBIO
Computed properties PubChem CID 129073603 · XLogP 3.1 · TPSA 136 Ų · H-bond donors 3
- XLogP
- 3.1
- TPSA
- 136 Ų
- H-bond donors
- 3
- H-bond acceptors
- 9
- Rotatable bonds
- 8
- Heavy atoms
- 39
SMILES CC1=CC(=NN1)NC2=NC(=NC(=C2)C)C3CCC(CC3)(C(=O)N[C@@H](C)C4=CN=C(C=C4)N5C=C(C=N5)F)OC
Computed descriptors from PubChem (CID 129073603), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il